Radioiodine for Hyperthyroidism Not Found to Be Associated With Incident Cancer Risk
In patients with hyperthyroidism, treatment with radioiodine is not associated with incident cancer in long-term follow-up.
Hannah Dellabella
Contributing Writer https://www.endocrinologyadvisor.com
Hannah Dellabella is a freelance writer for Haymarket Media. She holds an MFA in creative writing from Purdue University and a BA in creative writing and professional writing from Carnegie Mellon University. Previously, she was the associate editor for Clinical Advisor at Haymarket Media and an assistant editor for the Haymarket Medical Network. In addition to being a medical writer, Hannah is a poet whose work has appeared in various literary journals.
